Overview

Welcome to Dwaey, specifically on ACEREM 250mg Tablets page.
This medicine contains an important and useful components, as it consists of Acetazolamide.
ACEREM 250mg is available in the market in concentration 250mg/Tablet and in the form of Tablets.

REMEDICA LTD is the producer of ACEREM 250mg and it is imported from CYPRUS, The most popular alternatives of ACEREM 250mg are listed downward .

Mode Of Action & Indication

Acetazolamide specifically inhibits the enzyme carbonic anhydrase which catalyses the reversible reaction involving the hydration of CO2 and dehydration of carbonic acid. It increases the excretion of HCO3 ions and as well as Na and K leading to alkaline diuresis. Carbonic anhydrase is also inhibited in the CNS to retard abnormal and excessive discharge from neurons.

Indication

• Glaucoma
• Epilepsy
• Idiopathic intracranial hypertension
• Altitude sickness

Precaution

Potassium supplements may be required. Impaired hepatic or renal function; diabetes. Monitor plasma electrolytes and blood count regularly. IM route is not recommended. Caution when driving or operating machinery. Elderly. Lactation: Enters breast milk; not recommended

Side Effects

• Drowsiness
• paraesthesia
• ataxia
• dizziness
• thirst
• anorexia
• headache; confusion
• malaise
• depression; GI distress
• metabolic acidosis
• polyuria
• hyperuricaemia
• renal calculi
• nephrotoxicity
• hepatic dysfunction. Potentially Fatal: Rarely
• skin reactions or blood dyscrasias.

Contra indication

Hypersensitivity to sulphonamides; sodium or potassium depletion, hepatic insufficiency; hepatic cirrhosis; hyperchloraemic acidosis; severe renal impairment; severe pulmonary obstruction; chronic noncongestive angle-closure glaucoma; adrenocortical insufficiency. Pregnancy, lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks